Nucor earnings beat by $0.08, revenue fell short of estimates
STUART, Fla. - Health In Tech (NASDAQ:HIT), an Insurtech platform company that has seen its stock surge 67% in the past week, has regained compliance with Nasdaq’s minimum bid price requirement, the company announced Thursday.
The company received formal written confirmation from The Nasdaq Stock Market that it has satisfied the exchange’s listing rule 5550(a)(2), which requires listed companies to maintain a minimum closing bid price of $1.00 per share.
Health In Tech met the requirement by maintaining a closing bid price of $1.00 or higher for 10 consecutive business days from July 10 to July 23, 2025. Nasdaq Listing Qualifications Staff has notified the company that the matter is now closed.
Compliance with minimum bid price requirements is essential for companies to maintain their listing on the Nasdaq exchange. Companies that fail to meet this threshold risk receiving delisting notices and potentially being removed from the exchange.
Health In Tech describes itself as an Insurtech platform company that offers a marketplace aimed at improving processes in the healthcare industry through vertical integration, process simplification, and automation.
The announcement was made in a press release statement issued by the company.
In other recent news, Health In Tech Inc. reported its second-quarter earnings for 2025, showing a mixed financial performance. The company posted earnings per share of $0.01, which was below the forecasted $0.02, resulting in a 50% negative surprise. However, Health In Tech’s revenue reached $9.3 million, representing an 86% increase compared to the previous year. Despite the earnings miss, the significant revenue growth reflects the company’s expanding business activities. These developments have captured the attention of investors, as seen in the aftermarket session. While the company’s stock price movement is not detailed here, the financial results have sparked interest in the company’s future growth potential. Analysts and investors are likely to monitor Health In Tech closely for further developments.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.